Polysaccharide for enhancement of cardiac output

Details Polysaccharide for enhancement of cardiac output Polysaccharide for enhancement of cardiac output

1976-08-02

1979-05-15

Brown, Johnnie R.

Drug, bio-affecting and body treating compositions

Conjugate or complex of monoclonal or polyclonal antibody,...

Conjugated via claimed linking group, bond, chelating agent,...

536 1, 536 4, A61K 31715

Patent

active

041548221

ABSTRACT:
Polysaccharide substances--essentially consisting of rhamnose, galactose and galacturonic acid and preferably derived by extraction and purification of okra plant materials--are administered to provide selective rheological and hemodynamic effects and specifically to enhance cardiac output without substantial increment in circulatory (plasma) volume or concurrent inotropic, chronotropic or vasoactive effects.

REFERENCES:
patent: 3830910 (1974-08-01), Homsy
patent: 3849554 (1974-11-01), Winitz
patent: 3911915 (1975-10-01), Seifter et al.
Smith Thesis "The Subacute Toxicity of Intravenously Administered Okra Mucilage," Clemson U. Library, May, 1973.

Affiliated with

Also associated with

Rating

Polysaccharide for enhancement of cardiac output does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Polysaccharide for enhancement of cardiac output, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Polysaccharide for enhancement of cardiac output will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1097234